{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:07:43Z","timestamp":1793747263413,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00134-025-08110-w","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:27:59Z","timestamp":1758608879000},"page":"1820-1832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-5739","authenticated-orcid":false,"given":"Guillaume","family":"Monneret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Gossez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bodinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Friggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lepape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Allaouchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"10219","key":"8110_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395(10219):200\u2013211","journal-title":"Lancet"},{"issue":"22","key":"8110_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer NJ, Prescott HC (2024) Sepsis and septic shock. N Engl J Med 391(22):2133\u20132146","journal-title":"N Engl J Med"},{"issue":"8","key":"8110_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"1","key":"8110_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ et al (2024) The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol 25(1):19\u201328","journal-title":"Nat Immunol"},{"issue":"2","key":"8110_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14(2):121\u2013137","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"8110_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12):862\u2013874","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"8110_CR7","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3390\/biomedicines10092260","volume":"10","author":"JL Vincent","year":"2022","unstructured":"Vincent JL, van der Poll T, Marshall JC (2022) The end of \u201cone size fits all\u201d sepsis therapies: toward an individualized approach. Biomedicines 10(9):2260","journal-title":"Biomedicines"},{"key":"8110_CR8","doi-asserted-by":"publisher","first-page":"tkae073","DOI":"10.1093\/burnst\/tkae073","volume":"13","author":"A Kolodyazhna","year":"2025","unstructured":"Kolodyazhna A, Wiersinga WJ, van der Poll T (2025) Aiming for precision: personalized medicine through sepsis subtyping. Burns Trauma 13:tkae073","journal-title":"Burns Trauma"},{"issue":"4","key":"8110_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander S et al (2024) Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir Med 12(4):305\u2013322","journal-title":"Lancet Respir Med"},{"key":"8110_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2021","unstructured":"Torres LK, Pickkers P, van der Poll T (2021) Sepsis-induced immunosuppression. Annu Rev Physiol 84:157\u2013181","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"8110_CR11","first-page":"74","volume":"9","author":"F Pei","year":"2022","unstructured":"Pei F et al (2022) Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression. Mil Med Res 9(1):74","journal-title":"Mil Med Res"},{"key":"8110_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154137","volume":"72","author":"A Borouchaki","year":"2022","unstructured":"Borouchaki A et al (2022) Immunotherapy to treat sepsis induced-immunosuppression: immune eligibility or outcome criteria, a systematic review. J Crit Care 72:154137","journal-title":"J Crit Care"},{"key":"8110_CR13","doi-asserted-by":"crossref","unstructured":"Venet F et al (2021) Myeloid cells in sepsis-acquired immunodeficiency. Ann N Y Acad Sci 1499:3\u201317","DOI":"10.1111\/nyas.14333"},{"issue":"11","key":"8110_CR14","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1164\/rccm.200203-217OC","volume":"166","author":"T Fumeaux","year":"2002","unstructured":"Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166(11):1475\u20131482","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8110_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1182\/blood.V96.1.218","volume":"96","author":"K Wolk","year":"2000","unstructured":"Wolk K et al (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96(1):218\u2013223","journal-title":"Blood"},{"issue":"11","key":"8110_CR16","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/1521-4141(200011)30:11<3140::AID-IMMU3140>3.0.CO;2-O","volume":"30","author":"A Piani","year":"2000","unstructured":"Piani A et al (2000) Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol 30(11):3140\u20133146","journal-title":"Eur J Immunol"},{"issue":"8","key":"8110_CR17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","volume":"32","author":"G Monneret","year":"2006","unstructured":"Monneret G et al (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32(8):1175\u20131183","journal-title":"Intensive Care Med"},{"issue":"11","key":"8110_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","volume":"36","author":"C Landelle","year":"2010","unstructured":"Landelle C et al (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36(11):1859\u20131866","journal-title":"Intensive Care Med"},{"issue":"1","key":"8110_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-020-2830-x","volume":"24","author":"GP Leijte","year":"2020","unstructured":"Leijte GP et al (2020) Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Crit Care 24(1):110","journal-title":"Crit Care"},{"issue":"10","key":"8110_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30(10):475\u2013487","journal-title":"Trends Immunol"},{"key":"8110_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891024","volume":"13","author":"RQ Yao","year":"2022","unstructured":"Yao RQ et al (2022) Advances in immune monitoring approaches for sepsis-induced immunosuppression. Front Immunol 13:891024","journal-title":"Front Immunol"},{"key":"8110_CR22","first-page":"e20240179en","volume":"36","author":"JP Cidade","year":"2024","unstructured":"Cidade JP, Guerreiro G, Povoa P (2024) A clinical guide to assess the immune response to sepsis: from bench to bedside. Crit Care Sci 36:e20240179en","journal-title":"Crit Care Sci"},{"issue":"5","key":"8110_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/sur.2016.014","volume":"17","author":"N Galbraith","year":"2016","unstructured":"Galbraith N et al (2016) Past, present, and future of augmentation of monocyte function in the surgical patient. Surg Infect (Larchmt) 17(5):563\u2013569","journal-title":"Surg Infect (Larchmt)"},{"key":"8110_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/sur.2019.050","volume":"21","author":"E Dimitrov","year":"2019","unstructured":"Dimitrov E et al (2019) Poor outcome could be predicted by lower monocyte human leukocyte antigen-DR expression in patients with complicated intra-abdominal infections: a review. Surg Infect (Larchmt) 21:77\u201380","journal-title":"Surg Infect (Larchmt)"},{"issue":"11","key":"8110_CR25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s00134-010-1965-7","volume":"36","author":"JC Schefold","year":"2010","unstructured":"Schefold JC (2010) Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure. Intensive Care Med 36(11):1810\u20131812","journal-title":"Intensive Care Med"},{"issue":"7","key":"8110_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C et al (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180(7):640\u2013648","journal-title":"Am J Respir Crit Care Med"},{"key":"8110_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154330","volume":"78","author":"CH Vacheron","year":"2023","unstructured":"Vacheron CH et al (2023) Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: the GRID randomized controlled trial. J Crit Care 78:154330","journal-title":"J Crit Care"},{"issue":"3","key":"8110_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260\u2013268","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"8110_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13613-024-01302-5","volume":"14","author":"G Monneret","year":"2024","unstructured":"Monneret G, Payen D (2024) Immunostimulation in critically ill patients: do not forget to consider the timing, stratification, and monitoring. Ann Intensive Care 14(1):75","journal-title":"Ann Intensive Care"},{"issue":"12","key":"8110_CR30","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1373\/clinchem.2005.052639","volume":"51","author":"WD Docke","year":"2005","unstructured":"Docke WD et al (2005) Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 51(12):2341\u20132347","journal-title":"Clin Chem"},{"issue":"1","key":"8110_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/cyto.b.21043","volume":"84","author":"J Demaret","year":"2013","unstructured":"Demaret J et al (2013) Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytom B Clin Cytom 84(1):59\u201362","journal-title":"Cytom B Clin Cytom"},{"key":"8110_CR32","doi-asserted-by":"crossref","unstructured":"Gossez M et al (2024) Multicenter inter-laboratory quality control of monocyte HLA-DR expression by flow cytometry. Cytom B Clin Cytom 108(1):95\u201397","DOI":"10.1002\/cyto.b.22196"},{"issue":"1","key":"8110_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cyto.b.21987","volume":"100","author":"KJ Quadrini","year":"2021","unstructured":"Quadrini KJ et al (2021) A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials. Cytom B Clin Cytom 100(1):103\u2013114","journal-title":"Cytom B Clin Cytom"},{"issue":"5","key":"8110_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cyto.b.22025","volume":"102","author":"S Hamada","year":"2022","unstructured":"Hamada S et al (2022) Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA-DR expression in clinical samples. Cytom B Clin Cytom 102(5):384\u2013389","journal-title":"Cytom B Clin Cytom"},{"issue":"2","key":"8110_CR35","first-page":"190","volume":"80","author":"A Frugier","year":"2022","unstructured":"Frugier A et al (2022) Accreditation de la mesure de l\u2019expression des molecules HLA-DR a la surface des monocytes (mHLA-DR) par cytometrie en flux. Ann Biol Clin (Paris) 80(2):190\u2013198","journal-title":"Ann Biol Clin (Paris)"},{"issue":"1","key":"8110_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40635-017-0156-z","volume":"5","author":"M Zouiouich","year":"2017","unstructured":"Zouiouich M et al (2017) Automated bedside flow cytometer for mHLA-DR expression measurement: a comparison study with reference protocol. Intensive Care Med Exp 5(1):39","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"8110_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.CCM.0000150958.20209.A3","volume":"33","author":"A Pachot","year":"2005","unstructured":"Pachot A et al (2005) Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33(1):31\u201338 (discussion 236\u20137)","journal-title":"Crit Care Med"},{"key":"8110_CR38","doi-asserted-by":"crossref","unstructured":"Cajander S (2013) Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Crit Care 17:R223","DOI":"10.1186\/cc13046"},{"issue":"6","key":"8110_CR39","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/CCM.0000000000005832","volume":"51","author":"E Peronnet","year":"2023","unstructured":"Peronnet E et al (2023) Immune profiling panel gene set identifies critically ill patients with low monocyte human leukocyte antigen-DR expression: preliminary results from the REAnimation Low Immune Status Marker (REALISM) study. Crit Care Med 51(6):808\u2013816","journal-title":"Crit Care Med"},{"issue":"4","key":"8110_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/CCM.0000000000005270","volume":"50","author":"F Venet","year":"2022","unstructured":"Venet F et al (2022) Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury. Crit Care Med 50(4):565\u2013575","journal-title":"Crit Care Med"},{"key":"8110_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103300","volume":"85","author":"I Martin-Loeches","year":"2025","unstructured":"Martin-Loeches I et al (2025) Advocating for the recognition of underlying immunosuppression in critical illness. EClinicalMedicine 85:103300","journal-title":"EClinicalMedicine"},{"issue":"7","key":"8110_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S2213-2600(25)00124-9","volume":"13","author":"S Deinhardt-Emmer","year":"2025","unstructured":"Deinhardt-Emmer S et al (2025) Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies. Lancet Respir Med 13(7):623\u2013637","journal-title":"Lancet Respir Med"},{"issue":"7","key":"8110_CR43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41590-025-02180-0","volume":"26","author":"DS Khoury","year":"2025","unstructured":"Khoury DS et al (2025) Towards evidence-based immunology. Nat Immunol 26(7):980\u2013982","journal-title":"Nat Immunol"}],"updated-by":[{"DOI":"10.1007\/s00134-025-08161-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08110-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:36:27Z","timestamp":1760366187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08110-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8110"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08110-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00134-025-08161-z","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00134-025-08161-z","URL":"https:\/\/doi.org\/10.1007\/s00134-025-08161-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Maxime Bodinier is an employee of BioM\u00e9rieux. Other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This work was conducted in accordance with all ethical guidelines inherent to this type of study. Full details are provided in the Supplementary Methods section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on ethics approval"}}]}}